排序方式: 共有5条查询结果,搜索用时 0 毫秒
1
1.
2.
Syed Nusrath MS DNB Subramanyeshwar R. Thammineedi MS MCh Kalidindi Venkata Vijaya Narsimha Raju MS MCh Sujith C. Patnaik MS Ajesh R. Saksena MS DNB Jaya Karthik MS DNB Madhunarayana Basude MS DNB Pavan Kumar J MS MCh Srijan Shukla MS DNB Vishal B. Rao MD Kishore Kumar C M Pharm Swathi Gujjuru B Pharm Rohan Tewani MD DNB Tasneem Rushdie DNB Rashmi Sudhir MD Lynette M. Smith PhD Chandrakanth Are MD MBA FSSO FRCS FACS 《Journal of surgical oncology》2023,127(1):48-55
3.
Kim C. Ohaegbulam MD PhD Yilun Koethe MD Alice Fung MD FSAR Skye C. Mayo MD MPH FACS Aaron J. Grossberg MD PhD Emerson Y. Chen MD Kaveh Sharzehi MD MS Adel Kardosh MD PhD Khashayar Farsad MD PHD Flavio G. Rocha MD FACS FSSO Charles R. Thomas MD Nima Nabavizadeh MD 《Cancer》2023,129(2):184-214
Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere along the biliary tract. Surgical resection confers the greatest likelihood of long-term survivability. However, its insidious onset, difficult diagnostics, and resultant advanced presentation render the majority of patients unresectable, highlighting the importance of early detection with novel biomarkers. Developing liver-directed therapies and emerging targeted therapeutics may offer improved survivability for patients with unresectable or advanced disease. In this article, the authors review the current multidisciplinary standards of care in resectable and unresectable cholangiocarcinoma, with an emphasis on novel biomarkers for early detection and nonsurgical locoregional therapy options. 相似文献
4.
5.
Shilpa S. Murthy MD MPH Chandrakanth Are MD MBA FSSO FRCS FACS 《Journal of surgical oncology》2024,129(1):145-149
Over 5 billion people lack access to basic surgical procedures, and it is estimated, the number of surgical procedures needed for cancer care will increase by 5 million from 2018 to 2040. The greatest increase in demand will occur in low- and middle-income countries. In this article, we highlight progress made in surgical cancer care globally and gaps that still needs to be addressed. We highlight political support, workforce progress and shortages, impact of the COVID-19 pandemic, and the importance of high value cancer care 相似文献
1